Kriya Medical Technologies, a medical devices company headquartered in Chennai, has received its manufacturing license from the DCGI (Drugs Controller General of India) for its product KRIVIDA Novus, an RT-PCR kit that can detect the Omicron variant and its sub-lineages in 45 minutes.

Priced at Rs 150 +taxes, the test is affordable and most suitable for entry point screening at airports. The kit is compatible with Real-Time PCR machines with a test run time of roughly 45 minutes. It provides early report to aid diagnosis and also gives precise variants to enable appropriate treatment.

KRIVIDA Novus will be produced at Kriya’s state-of-the-art manufacturing facility in Oragadam in Chennai. The company currently has a production capacity of 5 million tests per month and plans to increase it to 10 million tests per month within the next two weeks.

Anu Moturi, CEO and Founder, Kriya Medical Technologies, said, “I thank the ICMR and DCGI for their swift action. Acquiring this license is yet another milestone and a step towards our vision of making good healthcare affordable and accessible to all. Our focus is to make testing for Covid-19 variants faster, affordable and accessible to everyone, thereby enabling swift prevention and timely treatment. Since KRIVIDA Novus can detect the Omicron variant (B.1.1.529) and all its sub-lineages, such as BA.1, BA.2 and BA.3 in 45 minutes, it is most ideal and beneficial for entry point screening at airports and remobilisation of normal conditions in workplace and institutions.”

Kriya Medical Technologies has a pipeline of new products that will be released in the market over the next few months to address rapidly evolving mutations and other allied infections.

All you need to know about KRIVIDA Novus
  • KRIVIDA Novus RT-PCR kit has been developed by KRIYA Medical technologies in collaboration with ImmuGenix Bioscience
  • KRIVIDA Novus kit can detect COVID-19 and differentiate the other variants from Omicron in single-tube assay.
  • Our KRIVIDA NOVUS kit is compatible with most Real-Time PCR machines with a test run time of 45 minutes, enabling the testing sites to conduct 2,160 tests within 24 hrs.
  • The kit detects SARS-CoV-2 using five different gene targets and it has a variant specific S gene probe for the newly emerged Omicron.
  • KRIVIDA Novus picks up all the sub-lineages of Omicron, such as, BA.1, BA.2 and BA.3
  • The test is most suitable for entry point screening at airports


KRIYA is a Make in India initiative. It’s an emerging Medical Device company headquartered in Chennai, India. The company is focused on innovating digitally integrated diagnostic solutions designed to expand access to affordable health care delivering good health for all.



Post a Comment

Previous Post Next Post
Like this content? Sign up for our daily newsletter to get latest updates.